retatrutide phase 2 for Obesity: Weight-Loss Data ESC 2024: Retatrutide improves lipid

It was originally developed for diabetes and is well-studied

Backbone flexibility controls the activity and specificity of a proteinprotein interface: specificity in snake venom metalloproteases

Tirzepatide expanded the field by targeting both GIP and GLP-1 pathways

Monitoring Regular blood glucose checks HbA1c every 36 months Screening for complications Complications Acute: Diabetic ketoacidosis (DKA), Hyperosmolar hyperglycemic state (HHS) Chronic: Microvascular: retinopathy, nephropathy, neuropathy Macrovascular: cardiovascular disease, stroke, peripheral artery disease To view or add a comment, sign in In patients with uncontrolled or resistant hypertension, could baxdrostat added to background therapy lead to a lower seated systolic blood pressure at 12 weeks

Or you might prefer a daily pill instead of weekly shots altogether

Causes and risk factors for death in diabetes: a competing-risk analysis from the SAVOR-TIMI 53 trial